Top Markets
Coin of the day
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc.

ICPT
Xếp hạng trong cổ phiếu #12019
Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the... Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational reach spans the United States, Europe, and Canada. The company currently markets Ocaliva, a medication functioning as a farnesoid X receptor (FXR) agonist. This drug is approved for the treatment of primary biliary cholangitis (PBC) in adults, specifically when administered alongside ursodeoxycholic acid. Beyond its existing approved indications, Intercept is actively investigating Ocaliva's potential for additional uses, notably including nonalcoholic steatohepatitis (NASH). Concurrently, it is progressing other drug candidates through various clinical and preclinical stages of development. In a collaborative effort, the company holds a licensing agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. Intercept distributes its products through a dual approach, utilizing both its proprietary commercial organization and a network of external third-party distributors. The company was founded in 2002 and is headquartered in New York, New York.
Giá cổ phiếu
$19.00
Đồng bộ lần cuối: 2023-11-14
Vốn hóa thị trường
$629.64M
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
0.00%
Quốc gia
US
Giao dịch Intercept Pharmaceuticals, Inc. (ICPT)

Danh mục

Lịch sử giá cổ phiếu của Intercept Pharmaceuticals, Inc. (ICPT)
Giá đóng cửa cao nhất: $18.99 vào 2023-11-01

Giá đóng cửa thấp nhất: $19.35 vào 2012-10-01
Lịch sử giá cổ phiếu của Intercept Pharmaceuticals, Inc. từ 2012 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2023 39.35%
2022 -16.08%
2021 -46.76%
2020 -74.21%
2019 16.21%
2018 65.23%
2017 -41.82%
2016 -32.31%
2015 8.19%
2014 138.13%
2013 92.89%
2012 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.20 -12.94%
AU
$138.18 473.58%
US
$759.27 7.20%
CH